Maravai Lifesciences Holdings (MRVI) Total Current Liabilities (2020 - 2026)

Maravai Lifesciences Holdings' Total Current Liabilities history runs 7 years deep, the most recent figure standing at $42.6 million for Q1 2026.

• On a quarterly basis, Total Current Liabilities fell 32.52% year-over-year to $42.6 million in Q1 2026; TTM through Mar 2026 was $42.6 million, a 32.52% decrease from a year earlier, with the FY2025 full-year figure at $44.9 million, down 21.16% from the prior year.
• Total Current Liabilities declined to $42.6 million in Q1 2026 per MRVI's latest filing, from $44.9 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $124.9 million in Q1 2023 and bottomed at $42.6 million in Q1 2026.
• The 5-year median for Total Current Liabilities is $69.7 million (2025), against an average of $77.7 million.
• Across the five-year window, Total Current Liabilities jumped 44.1% in 2023 and slumped 52.74% in 2024, its largest moves.
• Year by year, Total Current Liabilities stood at $110.1 million in 2022, then retreated by 20.59% to $87.5 million in 2023, then sank by 34.87% to $57.0 million in 2024, then decreased by 21.16% to $44.9 million in 2025, then fell by 5.11% to $42.6 million in 2026.
• Per Business Quant, the three latest MRVI Total Current Liabilities figures stand at $42.6 million (Q1 2026), $44.9 million (Q4 2025), and $61.6 million (Q3 2025).